RASENI, ALAN
 Distribuzione geografica
Continente #
NA - Nord America 228
EU - Europa 54
AS - Asia 28
AF - Africa 5
SA - Sud America 3
Totale 318
Nazione #
US - Stati Uniti d'America 226
IT - Italia 22
CN - Cina 19
DE - Germania 15
RU - Federazione Russa 7
PL - Polonia 4
VN - Vietnam 4
ZA - Sudafrica 4
CA - Canada 2
CZ - Repubblica Ceca 2
FR - Francia 2
NL - Olanda 2
SG - Singapore 2
BR - Brasile 1
CL - Cile 1
CO - Colombia 1
ID - Indonesia 1
IN - India 1
KR - Corea 1
SN - Senegal 1
Totale 318
Città #
Fairfield 28
Santa Cruz 18
Seattle 17
Buffalo 16
Cambridge 15
Beijing 13
Ashburn 12
Ann Arbor 9
Houston 8
Woodbridge 8
Trieste 7
Wilmington 5
Dong Ket 4
Napoli 4
Warsaw 4
Muizenberg 3
University Park 3
Yellow Springs 3
Boardman 2
Cividale del Friuli 2
Dallas 2
Las Vegas 2
Los Angeles 2
Ottawa 2
Phoenix 2
Pozzuolo del Friuli 2
Waltham 2
Wuhan 2
Bengaluru 1
Capua 1
Chicago 1
Clearwater 1
Columbus 1
Dakar 1
Easton 1
Fleming Island 1
Fuzhou 1
Jacksonville 1
Jakarta 1
Latina 1
Mountain View 1
Nanjing 1
Newnan 1
Nocera Inferiore 1
Norwalk 1
Nuremberg 1
Nürnberg 1
Paris 1
Portici 1
Rome 1
Saint Petersburg 1
San Diego 1
San Jose 1
Scranton 1
Shanghai 1
Silverton 1
Troia 1
Zipaquirá 1
Totale 227
Nome #
Effects of oral administration of silymarin in a juvenile murine model of non-alcoholic steatohepatitis, file e2913fdb-a0c8-f688-e053-3705fe0a67e0 175
An animal model for the juvenile non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, file e2913fda-9bbd-f688-e053-3705fe0a67e0 153
The potential role of omentin-1 in obesity-related metabolic dysfunction-associated steatotic liver disease: evidence from translational studies, file fd3b6926-6e59-42e5-bb39-2ab40c7283ca 8
Totale 336
Categoria #
all - tutte 675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 675


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201943 0 0 0 0 0 0 0 0 0 9 21 13
2019/202076 10 8 5 8 5 6 6 7 9 2 6 4
2020/202138 2 7 1 3 4 4 3 2 2 6 2 2
2021/202249 2 4 3 2 4 2 4 3 0 3 18 4
2022/202340 2 2 10 9 2 1 4 2 1 2 4 1
2023/202420 0 0 1 0 2 2 4 9 0 2 0 0
Totale 336